Avidian Wealth Solutions, LLC Sorrento Therapeutics, Inc. Transaction History

Avidian Wealth Solutions, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.0 - $4.9 $212,000 - $519,400	-106,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $13,950 - $21,690	-3,000 Reduced 2.75%	106,000 $493,000
Q3 2021 Nov 10, 2021	SELL	$7.41 - $10.99 $296 - $439	-40 Reduced 0.04%	109,000 $832,000
Q2 2021 Aug 09, 2021	SELL	$6.35 - $10.0 $514,350 - $810,000	-81,000 Reduced 42.62%	109,040 $1.06 Million
Q1 2021 May 05, 2021	SELL	$7.03 - $16.51 $2.72 Million - $6.4 Million	-387,460 Reduced 67.09%	190,040 $1.57 Million
Q4 2020 Feb 09, 2021	BUY	$5.76 - $11.95 $2.38 Million - $4.93 Million	412,500 Added 250.0%	577,500 $3.94 Million
Q3 2020 Nov 06, 2020	BUY	$6.17 - $18.82 $1.02 Million - $3.11 Million	165,000 New	165,000 $1.84 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.